期刊文献+

124例卵巢恶性生殖细胞肿瘤的预后因素 被引量:1

PROGNOSTIC FACTORS OF 124 CASES WITH MALIGNANT GERM CELL TUMORS OF THE OVARY
下载PDF
导出
摘要 目的 研究卵巢恶性生殖细胞肿瘤预后有关因素及合理的治疗方案。 方法 1980 年~1992 年本院收治的卵巢恶性生殖细胞肿瘤124 例,回顾性分析有关预后因素。 结果 恶性生殖细胞肿瘤五年生存率81 % ,病理类型、病期及合理的治疗是影响预后的重要因素。无性细胞瘤与非无性细胞瘤及各期间的五年生存率差异显著( P< 005) 。 结论 Ⅰ期及Ⅱ期无性细胞瘤患者行保留生育机能手术。 To study the therapeutic methods and the prognostic factors of malignant germ cell tumors of the ovary.METHODS From January 1980 to December 1992,124 cases of histologically confirmed malignant germ cell tumors of the ovary were treated in our hospital.All patients (≤40 years old) were retrospectively analysed.Factors analyzed were symptoms,FIGO staging,histologic type and treatment approaches.RESULTS The 5 year survival rate of malignant germ cell tumors of the ovary was 81%. The histologic type,staging and treatmant approaches were important prognostic fators.There was a significant difference in the survival rate between disgerminoma and nondisgerminoma.CONCLUSION Conservative surgery is possible for early stage patients wishing to preserve fertility.
出处 《中国癌症杂志》 CAS CSCD 1999年第3期181-183,共3页 China Oncology
关键词 生殖细胞肿瘤 外科手术 预后 卵巢肿瘤 Malignant germ cell tumors of ovary Surgery Prognosis
  • 相关文献

参考文献2

二级参考文献1

  • 1侯亚君,中华肿瘤杂志,1987年,9卷,311页

共引文献37

同被引文献13

  • 1Hudson CN,Slevin ML,Tebbutt H.Successful pregnancy after treatment of stage Ⅲ bilateral ovarian dysgerminoma[].British Journal of Obstetrics and Gynaecology.1995
  • 2Slayton RE,Park RC,Silverberg SG, et al.Vincristine, dactinomyoin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report)[].Cancer.1985
  • 3Einhorn LH,Donohue J.Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer[].Annals of Internal Medicine.1997
  • 4Gershenson DM,Kavanagh JJ,Copeland LJ, et al.Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin[].Cancer.1986
  • 5Bokemeyer C,Gerl A,Schoffski P, et al.Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer[].Journal of Clinical Oncology.1999
  • 6Schneider DT,Hilgenteld E,Schwabe D, et al.Acute myelogenous leukemia after treatment for malignant germ cell tumors in children[].Journal of Clinical Oncology.1999
  • 7Williams S,Blessing JA,Liao SY,et al.Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group[].Journal of Clinical Oncology.1994
  • 8Gershenson DM.Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors[].Journal of Clinical Oncology.1988
  • 9Zanetta G,Bonazzi C,Cantu M G,et al.Survival and reproductive function after treatment of malignant germ cell ovarian tumors[].Journal of Clinical Oncology.2001
  • 10Coppleson M.Gynecologic Oncology:fundamental principles and clinical practice[]..1992

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部